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INTRODUCTION:  Here,  we report  a case  of duodenal  intramural  metastasis  from  gastric  cancer,  which  is
extremely  rare.
PRESENTATION  OF  CASE:  A 72-year-old  man was  admitted  to our  hospital  with  a chief  complaint  of
lack  of  appetite  in  2010.  An endoscopic  evaluation  detected  a Borrmann  type  2 tumor  occupying
the  lesser  curvature  of the  gastric  body  and  antrum,  and  pyloric  stenosis.  The  patient  underwent
total  gastrectomy.  In  an  examination  of the resected  specimen,  a  type  2  tumor  was  identiﬁed  in
the  middle  gastric  body  and  antrum,  and  a submucosal  tumor  was  detected  in  the duodenal  bulb.
A  histopathological  examination  demonstrated  that  the  gastric  tumor  was  not contiguous  with  the
duodenal  submucosal  tumor.  A  microscopic  examination  demonstrated  that  the  gastric  tumor  was
a  moderately  to  poorly  differentiated  adenocarcinoma  and  displayed  lymphatic  permeation.  The
duodenal  submucosal  tumor  was  also  found  to be  an  adenocarcinoma  and  was  similar  to  the  gas-
tric  tumor;  therefore,  we  diagnosed  the  duodenal  tumor  as  an intramural  metastasis  from  gastric
cancer.
DISCUSSION:  The  most  common  route  of  metastasis  from  gastric  cancer  involves  hematogenous  metas-
tasis,  lymph  node  metastasis,  and  peritoneal  metastasis.  Intramural  metastasis  from  gastric  cancer  is
rare  and  has  been  reported  to be a variant  of  lymphogenic  metastasis.  The  clinicopathological  features  of
patients  with  duodenal  intramural  metastasis  from  gastric  cancer  are  unclear  because  only  one case  of
the  condition  has  been  reported.
CONCLUSION: Duodenal  intramural  metastasis  from  gastric  cancer  is an  advanced  form  of cancer,  and  we
suggest  that it  should  be treated  with  surgical  resection  followed  by  adjuvant  therapy.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. . Introduction
Esophageal squamous cell carcinoma is often accompanied by
ntramural metastasis. In fact, intramural metastases are found in
he esophagus in about 15% of esophageal cancer cases.1,2 On the
ther hand, intramural esophageal metastasis from gastric adeno-
arcinoma has rarely been reported.3–5 Furthermore, intramural
etastasis from gastric cancer to the duodenal wall is extremely
are, and only one case has been reported in the literature.6 Here,
e report a case of duodenal intramural metastasis from gastric
ancer.∗ Corresponding author at: Department of Surgery, Juntendo Shizuoka Hospital,
129  Nagaoka, Izunokuni-shi, Shizuoka 410-2295, Japan. Tel.: +81 55 948 3111;
ax: +81 55 946 0514.
E-mail  address: tomo-ito@juntendo.ac.jp (T. Ito).
210-2612     © 2013 Surgical Associates Ltd. Published by Elsevier Ltd.  
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Open access under CC B2. Presentation of case
In June 2010, a 72-year-old Japanese man was admitted to
our hospital with a chief complaint of lack of appetite. A physical
examination performed on admission demonstrated the follow-
ing characteristics: height, 163 cm;  weight, 57.0 kg; blood pressure,
127/70 mmHg; and pulse, 76 beats/min. No lymph nodes or tumors
were palpable, nor were his liver or spleen. A laboratory examina-
tion detected anemia (RBC: 287 × 104/l, Hb: 8.2 g/dl, Ht: 25.8%).
The patient’s serum levels of carcinoembryonic antigen (CEA), a
tumor marker, were normal, whereas those of carbohydrate anti-
gen 19-9 (CA19-9) were slightly increased (56 U/ml).
An upper gastrointestinal series demonstrated a Borrmann type
2 tumor occupying the lesser curvature of the gastric body and
antrum (Fig. 1). Upper gastrointestinal endoscopy showed a large
ulcerated tumor in the lesser curvature of the gastric body and
pyloric stenosis (Fig. 2), and we  could not insert the endoscope into
the duodenum. Biopsy specimens from the tumor demonstrated
moderately differentiated adenocarcinoma. A computed tomogra-
phy scan depicted thickening of the gastric wall and swelling of the
regional lymph nodes (Fig. 3).
Y-NC-ND license. 
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Fig. 3. Computed tomography scan demonstrating thickening of the gastric wallig. 1. Upper gastrointestinal series demonstrating a Borrmann type 2 tumor occu-
ying the lesser curvature of the gastric body and antrum.
Intraoperatively, no liver metastasis or peritoneal dissemina-
ion was identiﬁed. However, a solid mass, which looked like a
etastatic lymph node within the duodenal wall, was identiﬁed
n the duodenal bulb. The patient underwent total gastrectomy
nd lymph node resection. In an examination of the resected
pecimen, a type 2 tumor (8.5 cm × 6.5 cm)  was identiﬁed in the
esser curvature of the middle gastric body and antrum, and a
ubmucosal tumor, which overlay the irregular mucosa and mea-
ured 3.5 cm × 3.5 cm,  was identiﬁed in the duodenal bulb (Fig. 4).
 histopathological examination demonstrated that the gastric
umor was not contiguous with the submucosal duodenal tumor.
 microscopic examination disclosed that the gastric tumor was a
oderately to poorly differentiated adenocarcinoma that displayed
oderate lymphatic permeation. The duodenal submucosal tumor,
hich was mainly located in the muscle layer, but had also invaded
he mucosal layer, was  also found to be an adenocarcinoma and
as similar to the gastric tumor (Fig. 5). Metastases were found in
3 regional lymph nodes. The patient’s disease was staged as IIIc
pT4apN3M0) according to the TNM classiﬁcation.
Postoperatively, the patient was treated with S-1 adjuvant
hemotherapy. However, as he suffered nausea, a side effect of the
hemotherapy, he refused to continue the adjuvant chemotherapy.
ix months after the operation, the patient developed peritoneal
arcinomatosis, which resulted in his death at 14 months after the
peration.
Fig. 2. Upper gastrointestinal endoscopy showed a large ulcerated tumor iand swelling of the regional lymph nodes.
3. Discussion
Intramural metastasis from esophageal carcinoma is generally
associated with a poor prognosis after esophagectomy,1,2 and the
following macroscopic and histological criteria are used to deﬁne
the condition: (1) the metastatic lesion is clearly separated from the
primary tumor; (2) is located in the esophageal or gastric wall; (3)
displays the gross appearance of a submucosal tumor, but does not
exhibit intraepithelial cancer extension; (4) belongs to the same
histological type as the primary tumor; and (5) lacks any evidence
of intravascular growth.2 The present case did not fulﬁll one of these
criteria; i.e., although the duodenal lesion was a submucosal tumor
it displayed intraepithelial tumor extension. However, the duode-
nal tumor was  mainly located in the muscle layer and had invaded
the epithelium; therefore, we  diagnosed the duodenal tumor as an
intramural metastasis from gastric cancer.
Nishimaki et al.2 demonstrated that patients with intramu-
ral metastasis display extensive tumor spreading with either
lymphatic or blood vessel invasion and lymph node metasta-
sis. Therefore, the prognosis of patients who develop intramural
metastasis after esophagectomy is poor. Intramural metastasis has
been reported to be a variant of lymphogenic metastasis because
lymph node metastases and lymphatic invasion occur concurrently
in most patients with intramural metastasis.7–9 Similarly, in the
present case, metastases were detected in 13 lymph nodes, and
moderate lymphatic invasion was  also noted, suggesting that gas-
tric cancer cells had invaded the lymphatic vessels and duodenal
wall.
n the lesser curvature of the gastric body (a) and pyloric stenosis (b).
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Fig. 4. (a) In an examination of the resected specimen, a type 2 tumor
(8.5  cm ×6.5 cm)  was  detected in the lesser curvature of the middle gastric body
and  antrum, and a submucosal tumor (3.5 cm × 3.5 cm), which overlay the irregular
mucosa,  was  identiﬁed in the duodenal bulb. (b) and (c) A cross section of the short-
est axis between the gastric tumor and the duodenal lesion showed that the gastric
tumor was not contiguous with the duodenal lesion. Arrow: pylorus, arrowhead:
duodenal  lesion, paired arrowhead: gastric tumor.
Fig. 5. Histopathological examination demonstrating that the gastric tumor was  not co
viewed with a magnifying glass. (b) Hematoxylin and eosin stain, magniﬁcation, 20×. 
moderately to poorly differentiated adenocarcinoma (d) and that the duodenal submuc
(hematoxylin and eosin stain, magniﬁcation, 100×).PEN  ACCESS
ery Case Reports 4 (2013) 500– 503
The most common route of metastasis from gastric can-
cer involves hematogenous metastasis, lymph node metasta-
sis, and peritoneal metastasis.10,11 Intramural metastasis from
gastric cancer is rare, and intramural esophageal metasta-
sis from gastric adenocarcinoma has only been described in
a few reports.3–5 Szántó et al.5 reported that intramural
esophageal  metastases were detected in six of 143 patients
who were examined for suspected adenocarcinoma of the cardia
(4.19%).
Furthermore, intramural metastasis from gastric cancer to the
duodenal wall is extremely rare. The only case of this condi-
tion was reported by Mizutani et al. in the Japanese literature
in 2000.6 Their case involved a 75-year-old man, and total gas-
trectomy was performed. In addition, it was histopathologically
conﬁrmed that the gastric lesion and duodenal lesion were com-
posed of the same poorly differentiated adenocarcinoma cells, and
the primary tumor displayed lymphatic permeation. However, no
metastasis was  detected in the regional lymph nodes. The TNM
stage of the patient was  IIb (pT4apN0M0); however, the patient
was still alive at 12 months after the operation. As there has only
been one report of this condition, the clinicopathological features of
patients with duodenal intramural metastasis from gastric cancer
are unclear.
Our patient died of recurrent disease 14 months after under-
going surgery. We  also had to perform adjuvant chemotherapy
in the current case because the patient’s TNM stage was IIIc.
Szántó et al.5 reported that all of the intramural secondary
tumors that they encountered were considered to be advanced
forms of cancer. Therefore, we consider that patients that
develop intramural metastasis from gastric cancer after sur-
gical resection require adjuvant therapy. Several studies have
found that postoperative S-1 adjuvant chemotherapy or sys-
temic chemotherapy is effective at treating recurrent gastric
cancer.12,13 On the other hand, other studies have reported the
efﬁcacy of postoperative radiotherapy against recurrent gastric
cancer.14,15
ntiguous with the duodenal submucosal tumor. (a) Hematoxylin and eosin stain,
(c) and (d) Microscopic examination demonstrating that the gastric tumor was  a
osal tumor was  also an adenocarcinoma (c) and was  similar to the gastric tumor
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. Conclusion
Duodenal intramural metastasis from gastric cancer is consid-
red to be an advanced form of cancer, and we suggest that it should
e treated with surgical resection followed by postoperative adju-
ant therapy.
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